4.4 Article

The α-effect in cyclic secondary amines: new scaffolds for iminium ion accelerated transformations

Journal

TETRAHEDRON
Volume 65, Issue 48, Pages 9961-9966

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.tet.2009.10.009

Keywords

-

Funding

  1. EPSRC Mass Spectrometry Service
  2. Engineering and Physical Sciences Research Council [GR/S69337/01, EP/E018718/1] Funding Source: researchfish
  3. EPSRC [EP/E018718/1] Funding Source: UKRI

Ask authors/readers for more resources

Five-membered secondary amine heterocycles containing all alpha-heteroatom were prepared and shown to be ineffective as catalysts for the iminium ion catalysed Diels-Alder reaction between cinnamaldehyde and cyclopentadiene. Their six-membered counterparts proved to be highly active catalysts. In stark contrast, the catalytic activity observed when comparing the non alpha-heteroatom cyclic amines proline methyl ester and methyl pipecolinate showed the five-membered ring amine was significantly more active. Concurrent density functional theoretical calculations suggest a rationale for the observed trends in reactivity, highlighting that LUMO activation through all iminium ion intermediate plays a key role ill catalytic activity. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers

D. Gareth Evans, Siva Sithambaram, Elke Maria van Veen, George J. Burghel, Helene Schlecht, Elaine F. Harkness, Helen Byers, Jamie M. Ellingford, Ashu Gandhi, Sacha J. Howell, Anthony Howell, Claire Forde, Fiona Lalloo, William G. Newman, Miriam Jane Smith, Emma Roisin Woodward

Summary: This study aimed to investigate the frequency of germline pathogenic variants (PVs) in women with ductal carcinoma in situ (DCIS) and grade 1 invasive breast cancer (G1BC). The results showed that DCIS was more likely to be associated with both BRCA1/2 and non-BRCA1/2 PVs than G1BC. Extended panel testing is recommended for young-onset DCIS where PV detection rates are highest.

JOURNAL OF MEDICAL GENETICS (2023)

Letter Oncology

RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer

D. Gareth Evans, Emma R. Woodward

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

Jose Garcia-Pelaez, Rita Barbosa-Matos, Silvana Lobo, Alexandre Dias, Luzia Garrido, Sergio Castedo, Sonia Sousa, Hugo Pinheiro, Liliana Sousa, Rita Monteiro, Joaquin J. Maqueda, Susana Fernandes, Fatima Carneiro, Nadia Pinto, Carolina Lemos, Carla Pinto, Manuel R. Teixeira, Stefan Aretz, Svetlana Bajalica-Lagercrantz, Judith Balmana, Ana Blatnik, Patrick R. Benusiglio, Maud Blanluet, Vincent Bours, Hilde Brems, Joan Brunet, Daniele Calistri, Gabriel Capella, Sergio Carrera, Chrystelle Colas, Karin Dahan, Robin de Putter, Camille Desseignes, Elena Dominguez-Garrido, Conceicao Egas, D. Gareth Evans, Damien Feret, Eleanor Fewings, Rebecca C. Fitzgerald, Florence Coulet, Maria Garcia-Barcina, Maurizio Genuardi, Lisa Golmard, Karl Hackmann, Helen Hanson, Elke Holinski-Feder, Robert Huneburg, Mateja Krajc, Kristina Lagerstedt-Robinson, Conxi Lazaro, Marjolijn J. L. Ligtenberg, Cristina Martinez-Bouzas, Sonia Merino, Genevieve Michils, Srdjan Novakovic, Ana Patino-Garcia, Guglielmina Nadia Ranzani, Evelin Schrock, Ines Silva, Catarina Silveira, Jose L. Soto, Isabel Spier, Verena Steinke-Lange, Gianluca Tedaldi, Maria-Isabel Tejada, Emma R. Woodward, Marc Tischkowitz, Nicoline Hoogerbrugge, Carla Oliveira

Summary: This study analyzed families carrying rare CDH1 variants, comparing the cancer spectrum in carriers of pathogenic or likely pathogenic variants (PV/LPV) or missense variants of unknown significance, and evaluated the performance of expanded criteria for CDH1 testing. The results showed that PV/LPV carriers were positively associated with lobular breast cancer, diffuse gastric cancer, and gastric cancer, while missense variants of unknown significance did not show this positive association.

LANCET ONCOLOGY (2023)

Review Medicine, General & Internal

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

Charlotte Carton, D. Gareth Evans, Ignacio Blanco, Reinhard E. Friedrich, Rosalie E. Ferner, Said Farschtschi, Hector Salvador, Amedeo A. Azizi, Victor Mautner, Claas Roehl, Sirkku Peltonen, Stavros Stivaros, Eric Legius, Rianne Oostenbrink

Summary: This study aims to integrate information on NF1-associated tumors to assist healthcare professionals in tumor surveillance of NF1 individuals. Personalized and targeted tumor management proposals have been defined to ensure appropriate care for those in need.

ECLINICALMEDICINE (2023)

Review Obstetrics & Gynecology

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations

Denise R. Nebgen, Susan M. Domchek, Joanne Kotsopoulos, Joanne A. de Hullu, Emma J. Crosbie, Vincent Singh Paramanandam, Monique Brood van Zanten, Barbara M. Norquist, Theresa Guise, Serge Rozenberg, Allison W. Kurian, Holly J. Pederson, Nese Yuksel, Rachel Michaelson-Cohen, Sharon L. Bober, Agnaldo Lopes da Silva, Nora Johansen, F. Guidozzi, D. Gareth Evans, Usha Menon, Sheryl A. Kingsberg, C. Bethan Powell, Giovanni Grandi, Claudia Marchetti, Michelle Jacobson, Donal J. Brennan, Martha Hickey

Summary: Women with high inherited risk of ovarian cancer can undergo risk-reducing salpingo-oophorectomy (RRSO) between the ages of 35 and 45. While RRSO can save lives, it can also cause symptoms that negatively impact quality of life and long-term health. This scoping review explores the effects of RRSO on short- and long-term health and provides evidence-based international consensus recommendations for comprehensive care.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Oncology

Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic

Michelle Harvie, David P. French, Mary Pegington, Cheryl Lombardelli, Suzy Krizak, Katharine Sellers, Emma Barrett, D. Gareth Evans, Ramsey Cutress, Andrea Wilding Rgn, Lee Graves, Anthony Howell

Summary: This study compared the efficacy of two remotely delivered weight loss programs and written advice. The results showed that both weight loss programs resulted in more women achieving a weight loss of ≥10%, but there was no evidence of additional benefits from the multiple disease prevention program. Therefore, a multicenter RCT is warranted to test the weight loss program across breast cancer Family History, Risk and Prevention Clinics in the UK.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study

Robert D. Morgan, Andrew R. Clamp, Bethany M. Barnes, Kirsten Timms, Helene Schlecht, Laura Yarram-Smith, Yvonne Wallis, Mikel Valganon-Petrizan, Suzanne MacMahon, Rhian White, Sian Morgan, Sarah McKenna, Emma Hudson, Laura Tookman, Angela George, Ranjit Manchanda, Sudha S. Sundar, Shibani Nicum, James D. Brenton, Rebecca S. Kristeleit, Susana Banerjee, Iain A. McNeish, Jonathan A. Ledermann, Stephen S. Taylor, D. Gareth R. Evans, Gordon C. Jayson

Summary: This study reports data from the first year of routine homologous recombination deficiency testing in the NHS in England, Wales, and Northern Ireland, demonstrating the significant survival benefits of olaparib plus bevacizumab maintenance therapy in women with newly diagnosed, advanced, high-grade ovarian cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Editorial Material Genetics & Heredity

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Nicola Flaum, Emma J. Crosbie, Emma Roisin Woodward, Fiona Lalloo, Robert Morgan, Neil Ryan, D. Gareth Evans

JOURNAL OF MEDICAL GENETICS (2023)

Article Genetics & Heredity

TP53 c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma

D. Gareth Evans, Elaine F. Harkness, Emma R. Woodward

Summary: Germline TP53 variants, particularly the p.R337H and p.P152L, are associated with different cancer risks in Li-Fraumeni syndrome. The p.P152L variant is mainly linked to childhood adrenal tumors and has lower risks for non-adrenal tumors compared to the p.R337H variant. Understanding codon-specific cancer risks is crucial for individualized risk assessment and prevention strategies in LFS.

JOURNAL OF MEDICAL GENETICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Automatic assessment of mammographic density using a deep transfer learning method

Steven Squires, Elaine Harkness, Dafydd Gareth Evans, Susan M. Astley

Summary: This study aims to build automated models using deep learning based on the scores given by radiologists to predict mammographic breast density accurately and consistently. The approach involves using pretrained deep networks to generate feature vectors for regression analysis, and the results show that the model performs at a similar level to human experts in estimating cancer risk. The study also demonstrates the high consistency and potential of the model.

JOURNAL OF MEDICAL IMAGING (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

The effect of variable labels on deep learning models trained to predict breast density

Steven Squires, Elaine F. Harkness, D. Gareth Evans, Susan M. Astley

Summary: High breast density is associated with reduced efficacy of mammographic screening and increased breast cancer risk. Accurate automated density estimates can be used for risk prediction. However, expert reader assessments of density show variation and this variability affects the model's mapping from representation to prediction.

BIOMEDICAL PHYSICS & ENGINEERING EXPRESS (2023)

Article Psychology, Clinical

How do women at increased risk of breast cancer make sense of their risk? An interpretative phenomenological analysis

Victoria G. Woof, Lorna McWilliams, Anthony Howell, D. Gareth Evans, David P. French

Summary: This study aimed to gain an in-depth understanding of women's lived experiences of receiving an increased breast cancer risk. The findings suggest that providing risk predictions has little impact on women's beliefs about breast cancer risk, and discussions with healthcare professionals are needed to help women form more accurate appraisals and make informed decisions.

BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2023)

Article Clinical Neurology

The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma

Grace E. Gregory, Adam Paul Jones, Michael J. Haley, Christopher Hoyle, Leo A. H. Zeef, I-Hsuan Lin, David J. Coope, Andrew T. King, D. Gareth Evans, Pawel Paszek, Kevin N. Couper, David Brough, Omar N. Pathmanaban

Summary: Bilateral vestibular schwannoma is a characteristic feature of NF2-related schwannomatosis, which is associated with multiple surgical interventions, radiotherapy, and off-label use of bevacizumab. Unilateral vestibular schwannoma occurs sporadically in non-NF2-related schwannomatosis patients without drug treatment options. Tumour-infiltrating immune cells, especially macrophages and T-cells, play a role in the growth of vestibular schwannoma and show similarities between sporadic and NF2-related schwannomatosis tumours. However, there are differences in tumour presentation and patient characteristics between these two conditions. This study compared the tumour microenvironment of sporadic and NF2-related schwannomatosis vestibular schwannoma and found strong similarities in the immune profiles.

BRAIN COMMUNICATIONS (2023)

Article Oncology

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

Karin M. Kast, Esther L. John, John Hopper, Nadine Andrieu, Catherine Nogues, Emmanuelle Mouret-Fourme, Christine Lasset, Jean-Pierre Fricker, Pascaline Berthet, Veronique Mari, Lucie K. Salle, Marjanka Schmidt, Margreet G. E. M. Ausems, Encarnacion B. Gomez Garcia, Irma R. van de Beek, Marijke Wevers, D. Gareth Evans, Marc Tischkowitz, Fiona Lalloo, Jackie Cook, Louise Izatt, Vishakha Tripathi, Katie Snape, Hannah Musgrave, Saba Sharif, Jennie V. Murray, Sarah V. Colonna, Irene L. Andrulis, Mary B. Daly, Melissa C. Southey, Miguel de la Hoya, Ana Osorio, Lenka Foretova, Dita Berkova, Anne-Marie Gerdes, Edith Olah, Anna Jakubowska, Christian F. Singer, Yen Tan, Annelie Augustinsson, Johanna Rantala, Jacques Simard, Rita K. Schmutzler, Roger L. Milne, Kelly-Anne Phillips, Mary Beth Terry, David Goldgar, Flora E. van Leeuwen, Thea M. Mooij, Antonis C. Antoniou, Douglas F. Easton, Matti A. Rookus, Christoph Engel

Summary: The study found that height, body mass index (BMI), and weight gain are associated with breast cancer risk in the general population. It is unclear whether these associations also exist for carriers of pathogenic variants in the BRCA1 or BRCA2 genes.

BREAST CANCER RESEARCH (2023)

Article Health Care Sciences & Services

Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program

Stuart J. Wright, Martin Eden, Helen Ruane, Helen Byers, D. Gareth Evans, Michelle Harvie, Sacha J. Howell, Anthony Howell, David French, Katherine Payne

Summary: This study identified and quantified the resource use and associated costs of introducing a breast cancer risk-stratification approach into the English national breast screening program. Findings showed that using questionnaires and automated breast density measurement for risk prediction had low costs, but adding SNP testing significantly increased the costs.

MDM POLICY & PRACTICE (2023)

Article Chemistry, Organic

Facile synthesis of quinoxaline catalyzed by iron-based carbon material in water

Fuying Zhu, Yamei Lin

Summary: In this study, a low-metal iron-supported catalyst (Fe20/NC-Mg) was reported for the efficient synthesis of quinoxaline compounds, using water as a solvent and without additional bases. The synergistic effect of FeNx site and Mg (OH)2 nanorods in the catalyst played a key role in achieving high yields (82-91%) in 16 examples. The gram-level synthesis and reusability of the catalysts after four cycles demonstrated its industrial application potential.

TETRAHEDRON (2024)

Article Chemistry, Organic

Simple approach towards phosphorus-substituted spiro 1,3,4-thiadiazolines

Mikhail Kozlov, Alexey Tyurin, Andrey Dmitrenok, Vyacheslav Rusak, Aleksander Fedorov, Igor Zavarzin, Yulia Volkova

Summary: This study presents a novel and practical synthesis method for phosphorus-substituted 1,3,4-thiadiazolines using phosphorylthioformic acid hydrazides and ketones. The protocol demonstrates operational simplicity, availability of reagents, and tolerance towards different functional groups.

TETRAHEDRON (2024)

Article Chemistry, Organic

Recent advances in the synthesis of 2-cyclopentenones

Jisna Jose, Thomas Mathew

Summary: 2-Cyclopentenone and its derivatives are highly esteemed synthetic intermediates with exceptional utility in organic synthesis. They are favored structural motifs in numerous pharmaceutical drugs and natural products, highlighting their significance. The review discusses the various methods used to synthesize cyclopentenones from 2016 to 2023.

TETRAHEDRON (2024)